Furthermore, it has been shown that, as demonstrated for other scaffold proteins such as CD2AP [28], ZO-1 [29] and NEPHRIN [30] itself, the expression of MAGI2 is reduced in glomerulopathies. This evidence concerns the gene MAGI2 and lipoprotein glomerulopathy.